Cargando…
Sustained Intraocular Pressure Elevation After Intravitreal Injection of Bevacizumab and Ranibizumab Associated with Trabeculitis
Anti-vascular endothelial growth factor agents are frequently used to treat a variety of ocular neovascular diseases. While agents like bevacizumab and ranibizumab appear to be safe and effective, there have been reports of severe intraocular inflammation as well as sustained elevation of intraocula...
Autores principales: | Sniegowski, Matthew, Mandava, Naresh, Kahook, Malik Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944993/ https://www.ncbi.nlm.nih.gov/pubmed/20871754 http://dx.doi.org/10.2174/1874364101004010028 |
Ejemplares similares
-
Evaluation of intraocular pressure elevation after multiple injections of intravitreal ranibizumab
por: Yu, Alice L, et al.
Publicado: (2014) -
Intraocular Pressure Changes after Intravitreal Bevacizumab or Ranibizumab Injection: A Retrospective Study
por: Mansoori, Tarannum, et al.
Publicado: (2021) -
Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab
por: Lee, Jong Wook, et al.
Publicado: (2016) -
Intraocular Pressure Elevation Following Intravitreal Anti-VEGF Injections: Short- and Long-term Considerations
por: Levin, Ariana M., et al.
Publicado: (2021) -
Immediate effect of intravitreal injection of bevacizumab on intraocular pressure
por: Lemos-Reis, Ricardo, et al.
Publicado: (2014)